Validation Accelerated

There’s always a need for speed with drug development. But Asymchem redefined expectations: moving from zero to validation in 14 months.

Challenge

A major pharma company’s need for scale-up and validation of a cGMP intermediate had been delayed for a while when the US FDA suddenly granted it priority status. Almost overnight, validation and supply were required.